Y 90 Ibritumomab Tiuxetan
[An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called IDEC-Y2B8 monoclonal antibody. ( NCI )]
UMLS (NCI) C1134535Yttrium Y 90 Ibritumomab Tiuxetan
yttrium Y90 ibritumomab tiuxetan
Yttrium-90 Ibritumomab Tiuxetan
yttrium Y90 ibritumomab tiuxetan
Yttrium-90 Ibritumomab Tiuxetan
- Amino Acid, Peptide, or Protein
- Pharmacologic Substance
- Immunologic Factor
Buy website
Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.Affordable prices from $100.
  |
home
